By Nicola Miller, RARE Revolution Magazine
Interview with Dr David Kuter, distinguished physician, Massachusetts General Hospital and professor of Medicine at Harvard Medical School.

Dr. David Kuter shares how a novel therapy targeting CD38 receptors is showing promising results for those living with immune thrombocytopenia (ITP)

---